Cannascend Ohio

Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform.

Connected health tracker for cancer patients -- We are building a digital health platform with a mobile app to help patients track their health and symptoms that connects them through a web-based platform (or EHR integration) to their doctors. The app uses voice-to-text to make it easier for patients to express themselves. We connect patients to their doctors for real-time analysis to improve outcomes and improve the quality of life of patients. This company is inspired by my professional experience as a doctor with 12 years of clinical research experience and my personal experience with my father who was diagnosed with 3 different cancers -- colon, lung, and pancreatic cancer. From these experiences, I identified a problem. Doctors want patients to track and report any concerning daily symptoms. Cancer patients are already stressed. As a result, patient compliance is poor and inconsistent. The effect of all this is that: some side effects are not reported early become worse, costs go up, treatment takes longer, and patients end up have more stress. We are building a solution to these problems to help improve the lives of patients, improve outcomes for patients and doctors and decrease healthcare costs for employers and insurers.

Carefeed provides a HIPAA secure SaaS platform that digitizes any materials senior communities share with their various stakeholders. It automates antiquated and time-consuming processes by using text, email, voice, and video to distribute critical updates and announcements. It also helps family and friends to schedule visits on their own and receive updates when their resident is scheduled for any appointments.